FMC: Q3 Earnings Snapshot

FMC Corp. reported a Q3 loss of $2.07B ($15.54 per share) missing estimates of $0.08 per share. Revenue was $105.9M. Q4 guidance: EPS $0.56-$0.70, revenue $1.04B-$1.14B. Full-year loss expected at $3.50-$3.66 per share, revenue $2.75B-$2.85B.

Original reporting
Published Oct 29, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FMC: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$FMCBearishMed
01

Why it matters

The key tradable elements are the Q3 loss versus expectations and the company’s explicit EPS and revenue guidance for the current quarter and full year.

02

Market read

Provides fresh earnings and guidance numbers that can drive immediate repricing of FMC’s earnings power and risk premium.

03

What to watch

The article cites adjusted losses excluding certain pretax expenses and restructuring costs, so traders may need to reconcile headline loss versus underlying profitability drivers before positioning.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session reaction to Q3 results and updated Q4 and full-year guidance

Background

AP automated earnings snapshot for FMC’s third quarter, including EPS, revenue, and forward guidance ranges.

Company-level read

Ticker impact

$FMCBearishHigh confidence
Context

FMC reported a Q3 loss of $15.54 per share and guided Q4 revenue to $1.04B-$1.14B, missing analyst expectations.

Expected impact

Likely downside pressure as the market digests the larger-than-expected loss and the guided loss range for the current fiscal year.

Evidence & confidence

The article provides the company’s own Q3 results versus consensus and includes forward EPS and revenue ranges, which are direct inputs to near-term valuation.

Market effects

Signals continued earnings pressure in chemicals, potentially reinforcing cautious sentiment around commodity-linked industrial demand.

Limited, as the disclosure is company-specific rather than a broad regional macro shock.

Low, unless FMC’s guidance is interpreted as a read-through for global chemical demand conditions.

Counterpoint

Investors may focus on the guided revenue range and treat the loss as driven by restructuring or pretax items, looking for stabilization rather than deterioration.

Key entities

  • FMC Corp.

    Chemical producer reporting Q3 loss and issuing Q4 and full-year guidance ranges.

Related articles

$FMCHigh

KeyBanc downgrades FMC stock rating on turnaround concerns

KeyBanc downgraded FMC Corp. (NYSE:FMC) to Sector Weight, citing risks to its turnaround efforts. The stock, at $5.21, has fallen 61.5% in a year. KeyBanc set a fair value of $5.50, while InvestingPro's analysis suggests a Fair Value of $6.36. FMC plans to raise $1 billion, including $400 million in equity, and anticipates a return to growth in 2027. Jefferies initiated coverage with a Hold rating and a $6.00 price target.

$FMCMed

Fresenius Medical cuts top end of 2026 profit outlook

Fresenius Medical Care adjusted its 2026 operating income outlook, now expecting a flat to mid-single-digit percentage decline, down from a previous range of decline to increase. Q3 operating income fell 5% to €545 million, while revenue grew 1% to €4.94 billion. US same-market treatments declined 1.1%. The company faces regulatory and inflation challenges under new CEO Shervin J. Korangy.

$FMCHighAI 8/10

Why FMC Corporation Rallied Today

FMC Corporation (NYSE:FMC) shares surged 30.4% after Q3 earnings, despite an 80% revenue drop to $106M and a loss of $4.41 per share. The decline was partly due to one-time price cuts and accounting adjustments. Management guided Q4 revenue to $1.11B and positive EBITDA of $220M, with expectations of $650M EBITDA in 2024 and $760M in 2028.

$FMCHighAI 9/10

FMC Q3 Earnings Call Highlights

FMC reported Q3 revenue of $1.06B, including $639M from commercial actions, and adjusted EBITDA of -$559M. Q4 outlook was lowered, with revenue expected at $1.04B-$1.14B and adjusted EBITDA at $210M-$230M. FMC cited market challenges and pricing headwinds. The company expects full-year free cash flow to be -$350M to -$150M, including restructuring spending. FMC also announced preliminary 2027 and 2028 adjusted EBITDA targets of $650M-$730M and $760M-$840M, respectively.

$FMCHighAI 8/10

FMC (FMC) Q3 2026 Earnings Call Transcript

FMC reported Q3 2026 earnings, including a $672M EBITDA impact from commercial actions. Revenue was $106M, with underlying sales at $745M, below guidance. Adjusted EBITDA was negative $559M. The company is changing its North America business model and adjusting prices to reduce channel inventory. Q4 revenue is expected to be $1.04B-$1.14B, with adjusted EBITDA between $210M-$230M.